RGBAD Stock Price, News & Analysis
Company Description
RGBAD (OTC: RGBAD) is a publicly traded biotechnology company in the Healthcare sector.
RGBAD stock has declined 19.4% over the past year.
This page provides a comprehensive overview of RGBAD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
RGBAD (RGBAD) stock. Over the past 12 months, the stock has lost 19.4%.
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RGBAD Company Profile & Sector Positioning
RGBAD (RGBAD) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing RGBAD often look at related companies in the same sector, including Aspire Biopharma Holdings Inc (ASBPW), 180 Life Sciences Corp (ATNFW), Biocardia (BCDAW), Briacell Therapeutics Corp (BCTXW), and Briacell Therapeutics Corp (BCTXZ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RGBAD's relative position within its industry.